Recursion Pharmaceuticals (RXRX) Appoints Robert Hershberg as Board Chair

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. NDAQ
9. TSCO
10. BE

Go back to Recursion Pharmaceuticals (RXRX) Appoints Robert Hershberg as Board Chair

Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board

May 24, 2024 4:30 PM EDT

Dr. Hershberg is a current board member with over 25 years of experience as a physician, scientist, and entrepreneur

SALT LAKE CITY, May 24, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced that Robert Hershberg, M.D., Ph.D, has been appointed the new Chair of the Board of Recursion, effective at the end of this term, as Martin Chavez exits after more than four years of leadership.

Im excited to bring my clinical and scientific expertise to... More